Comparison
The two peptides most heavily marketed for recovery in Australia, often sold together. Here’s how they compare on evidence, legal status and risk — without any dosing or protocols.
Neither is an approved Australian medicine, and both are commonly sold through unregulated channels that are not a lawful supply pathway for human use.
For both, the human evidence is thin and the practical risk is product quality. The differences between them matter far less than their shared regulatory and safety problems.
They are often marketed as a “stack”, but we don’t publish protocols or dosing. Both are unapproved in Australia, so the more relevant point is that neither has a lawful general supply pathway.
This is general education, not medical advice. Peptides.au does not sell, supply, recommend or promote any product or clinic. Always speak with a registered Australian health practitioner before making any health decision.